Form 4: UNITED THERAPEUTICS Director Receives Stock Grant
Insider Transaction (Form 4)
Nilda Mesa, a Director of UNITED THERAPEUTICS Corp, reported multiple transactions in common stock on July 22, 2026.
Summary
- Grant/award: acquired 380 Restricted Stock Unit on July 22, 2026; holds 380 after (Direct).
- Grant/award: acquired 1,190 Stock Option on July 22, 2026; holds 1,190 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Nilda Mesa — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Grant/award | Restricted Stock Unit | 380 | — | — | 380 |
| 2026-07-22 | Grant/award | Stock Option | 1,190 | — | — | 1,190 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Grant/award (380 shares) |
| 2026-07-22 | Grant/award (1,190 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, neutral, Nilda Mesa
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.